|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 718 articles |
 Page 1 of 10 
|
Canadian pharmacy and California business unite against Rx re-imports.
August 30, 2004
Vermont files suit against FDA.
August 30, 2004
USP plan for Medicare Rx benefit groups.
August 30, 2004
Irish surprise at Illinois Rx-buying moves.
August 30, 2004
Slowdown in French health spending.(Brief Article)
August 30, 2004
France to reimburse Baxter's Advate.(Brief Article)
August 30, 2004
Guilford plans two new trials for Aggrastat.(Brief Article)
August 30, 2004
Mylan says FTC clearance of Icahn share buying responsible for stock r...
August 30, 2004
FDA OKs extension of expiry date for Taxus Express2 paclitaxel-eluting...
August 30, 2004
Merck & Co and Kyorin extend antibiotic deal.(Brief Article)
August 30, 2004
FDA OKs 2nd indication for Lilly's Alimta.(Brief Article)
August 30, 2004
ID Bio provides 2004 guidance.(Brief Article)
August 30, 2004
IVAX response to Australia patent news.(Brief Article)
August 30, 2004
Lilly ICOS claims increased market share for Cialis.(Brief Article)
August 30, 2004
Picchio Pharma ups its share of Neurochem.(PP Luxco Holdings)(Brief Ar...
August 30, 2004
EC OKs Yamanouchi and Fujisawa merger.(Brief Article)
August 30, 2004
Apax Partners forms Aerovance via spin out of Bayer projects.(Brief Ar...
August 30, 2004
Cobalis requires mandatory share certificate exchange.(Brief Article)
August 30, 2004
Novartis' Zelnorm gets FDA OK for new use.(US Food and Drug Administra...
August 30, 2004
Bioenvision's clofarabine filed in EU.(Brief Article)
August 30, 2004
HuMax-CD4 gets FDA Orphan Drug status.(Brief Article)
August 30, 2004
Warner Chilcott's Femtrace cleared in USA.(Brief Article)
August 30, 2004
HGS' TRAIL agonist enters clinic for cancer.(Brief Article)
August 30, 2004
FDA and Centocor issue Remicade warning.(Brief Article)
August 30, 2004
Maelor names Volpex S Korea distributor.(Brief Article)
August 30, 2004
Metaphore raises $40M.(Brief Article)
August 30, 2004
BASF inaugurates citral plant, part of 300M-euro investment.(Brief Art...
August 30, 2004
Australian biotech and generics groups warn over AUSFTA amendments.
August 30, 2004
Rx marketing conference.(Brief Article)
August 30, 2004
German reform works to produce health fund surplus.
August 30, 2004
US Appeals Court to decide on US claims in Roche fraud case.(Brief Art...
August 30, 2004
Are patients taking adequate asthma therapies?(Brief Article)
August 30, 2004
Allergan sues Alcon on patent infringement.(Brief Article)
August 30, 2004
Benitec in HIV/AIDS collaboration.(Brief Article)
August 30, 2004
ADHD impacts entire families, study shows.(Brief Article)
August 30, 2004
Berna's share price slips as 1st-half losses rise.(Brief Article)
August 30, 2004
Pfizer's Geodon gets FDA OK for new use.(Brief Article)
August 30, 2004
Roche's Xeloda filed for new indication.(Brief Article)
August 30, 2004
Vitamin E helps fight colds in the elderly.(Brief Article)
August 30, 2004
Tomato juice may benefit diabetics.(Brief Article)
August 30, 2004
Germany's Merck buys Pfizer's Scandinavian generic unit for $66.5M.
August 30, 2004
Hofstaetter to quit Sanofi-Aventis.(Brief Article)
August 30, 2004
Cyberonics raises 2nd-qtr guidance, discloses regulatory options.(Brie...
August 30, 2004
Artemis and Acceleron cooperate in mouse genetics.(Brief Article)
August 30, 2004
Medicure cash pile, and losses, grow.(Brief Article)
August 30, 2004
Stiefel licenses Sebiprox to Ferrer.(Brief Article)
August 30, 2004
Celgene's adverse drug reports were late, says FDA.(Brief Article)
August 30, 2004
Merrimack completes enrollment of MM-093 trial for rheumatoid arthriti...
August 30, 2004
Improved bowel cancer test on the horizon?(Brief Article)
August 30, 2004
Ligand faces false information suit.(Brief Article)
August 30, 2004
Generex expands JV with PharmaBrand.(Brief Article)
August 30, 2004
Santarus initiates pivotal trial of Zegerid.(Brief Article)
August 30, 2004
Bavarian Nordic's first-half income plummets.(Brief Article)
August 30, 2004
Indena presents new studies of taxane derivatives.(Brief Article)
August 30, 2004
New guidances from UK NICE on hypertension, eczema and dyspepsia.
August 30, 2004
Tarceva filed in EU for advanced NSCL cancer.(Brief Article)
August 30, 2004
Ilex to update clofarabine NDA.(Brief Article)
August 30, 2004
Orphan status for Seattle's SGN-40 in MM.(Brief Article)
August 30, 2004
Pharmos sells around $17M common stock.(Pharmos Corp )(Brief Article)
August 30, 2004
US MMA triggering changes to pharma business model, says F&S.(US Medic...
August 30, 2004
US FDA pediatric antidepressant use review update; public meeting Sept...
August 30, 2004
Pharming acquires PPL patent portfolio.(Pharming Group NV)(PPL Therape...
August 30, 2004
Wyeth oncology researchers honored.(Brief Article)
August 30, 2004
Vernalis draws down from Endo loan, repays Elan.(Brief Article)
August 30, 2004
Medicis' full-year sales grow 23%.(Brief Article)
August 30, 2004
Centocor extends license to MorphoSys' antibody.(Brief Article)
August 30, 2004
Pharmos gets $16.75M gross proceeds from stock release.(Brief Article)
August 30, 2004
XTLbio gets FDA OK to re-open HepeX-C trial.(Brief Article)
August 30, 2004
Orphan Drug status for BioCryst's forodesine.(Brief Article)
August 30, 2004
Blueberries may lower cholesterol; new study.
August 30, 2004
Link between creatine and metabolic energy.(Brief Article)
August 30, 2004
Pfizer fails to stop IVAX' generic Neurontin.(Brief Article)
August 30, 2004
GSK prevails in Teva Zofran patent dispute.(Brief Article)
August 30, 2004
Novartis CEO reiterates acquisition stance.(Brief Article)
August 30, 2004
Vitex shareholder meeting on Panacos merger rescheduled.(Brief Article...
August 30, 2004
|
1